Abilify is a common medication licensed for the treatment of bipolar disorder, schizophrenia, autism, and major depression (when used with antidepressants). Although it is not a cure for these conditions, it can control symptoms and help keep them from returning. The tablets come in a number of strengths and are generally taken once a day. Possible side effects include nausea, insomnia, headaches, and anxiety.
Abilify belongs to a group of medications called atypical (or second-generation) antipsychotic medications. It is not entirely clear how this medication works for the treatment of schizophrenia, bipolar disorder, autism, or major depression.
However, it is known to block or lessen the effects of several chemicals in the brain. These chemicals (such as dopamine and serotonin) may be elevated in people with schizophrenia or bipolar disorder (also known as manic depression).
Written by/reviewed by: Kristi Monson, PharmD;Arthur Schoenstadt, MD
Last reviewed by: KristiMonson, PharmD;
List of references (click here):
Abilify [package insert]. Rockville, MD: Otsuka America Pharmaceutical, Inc.;2013 July.
Food and Drug Administration, Center for Drug Evaluation and Research. Electronic orange book: Approved drug products with therapeutic equivalence evaluations. FDA Web site. Available at: http://www.fda.gov/cder/ob/. Accessed February 29, 2008.
Briggs GG, Freeman RK, Yaffe SJ. Drugs in Pregnancy and Lactation. 7th ed. Philadelphia (PA): Lippincott Williams & Wilkins;2005.
National Library of Medicine (US). Drugs and Lactation Database (LactMED). NLM Web site. Available at: http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?LACT. Accessed April 30, 2007.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind.
Site users seeking medical advice about their specific situation should consult with their own physician. Click